Loss of Heterozygosity at 1p, 7q, 17p, and 22q in Meningiomas |
Chang, In-Sok
(Department of Neurosurgery, Hallym University College of Medicine)
Cho, Byung-Moon (Department of Neurosurgery, Hallym University College of Medicine) Moon, Seung-Myung (Department of Neurosurgery, Hallym University College of Medicine) Park, Se-Hyuck (Department of Neurosurgery, Hallym University College of Medicine) Oh, Sae-Moon (Department of Neurosurgery, Hallym University College of Medicine) Cho, Seong-Jjn (Department of Pathology, Hallym University College of Medicine) |
1 | Martinez-Rumayor A, Arrieta O, Guevara P, Escobar E, Rembao D, Salina C, et al. : Coexpression of hepatocyte growth factor/scatter factor (HGF/SF) and its receptor cMET predict recurrence of meningiomas. Cancer Lett 213 : 117-124, 2004 DOI ScienceOn |
2 | Riemenschneider MJ, Perry A, Reifenberger G : Histological classification and molecular genetics of meningiomas. Lancet Neurol 5 : 1045-1054, 2006 DOI ScienceOn |
3 | Kim JH, Lee SH, Rhee CH, Park SY, Lee JH : Loss of heterozygosity on chromosome 22q and 17p correlates with aggressiveness of meningiomas. J Neurooncol 40 : 101-106, 1998 DOI ScienceOn |
4 | Weber RG, Bostrom J, Wolter M, Baudis M, Collins VP, Reifenberger G, et al. : Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas : toward a genetic model of meningioma progression. Proc Natl Acad Sci U S A 94 : 14719-14724, 1997 DOI ScienceOn |
5 | Simon M, von Deimling A, Larson JJ, Wellenreuther R, Kaskel P, Waha A, et al. : Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas : a genetic model of meningioma progression. Cancer Res 55 : 4696-4701, 1995 |
6 | Sulman EP, Dumanski JP, White PS, Zhao H, Maris JM, Mathiesen T, et al. : Identification of a consistent region of allelic loss on 1p32 in meningiomas : correlation with increased morbidity. Cancer Res 58 : 3226-3230, 1998 |
7 | Ueki K, Wen-Bin C, Narita Y, Asai A, Kirino T : Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas. Cancer Res 59 : 5995-5998, 1999 |
8 | Zhou CZ, Qiu GQ, Zhang F, He L, Peng ZH : Loss of heterozygosity on chromosome 1 in sporadic colorectal carcinoma. World J Gastroenterol 10 : 1431-1435, 2004 |
9 | Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Millasseau P, et al. : A second-generation linkage map of the human genome. Nature 359 : 794-801, 1992 DOI ScienceOn |
10 | Zankl H, Zang KD : Cytological and cytogenetical studies on brain tumors. 4. Identification of the missing G chromosome in human meningiomas as no. 22 by fluorescence technique. Humangenetik 14 : 167-169, 1972 DOI |
11 | Maulik G, Shrikhande A, Kijima T, Ma PC, Morrison PT, Salgia R : Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev 13 : 41-59, 2002 DOI ScienceOn |
12 | Moriyama T, Kataoka H, Kawano H, Yokogami K, Nakano S, Goya T, et al. : Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans. Cancer Lett 124 : 149-155, 1998 DOI ScienceOn |
13 | Niedermayer I, Feiden W, Henn W, Steilen-Gimbel H, Steudel WI, Zang KD : Loss of alkaline phosphatase activity in meningiomas : a rapid histochemical technique indicating progression-associated deletion of a putative tumor suppressor gene on the distal part of the short arm of chromosome 1. J Neuropathol Exp Neurol 56 : 879-886, 1997 DOI ScienceOn |
14 | Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, et al. : Mutations in the p53 gene occur in diverse human tumour types. Nature 342 : 705-708, 1989 DOI ScienceOn |
15 | Pykett MJ, Landers J, George DL : Expression patterns of the p53 tumor suppressor gene and the mdm2 proto-oncogene in human meningiomas. J Neurooncol 32 : 39-44, 1997 DOI ScienceOn |
16 | Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P : p53 mutations in nonastrocytic human brain tumors. Cancer Res 51 : 6202-6205, 1991 |
17 | Park M, Dean M, Cooper CS, Schmidt M, O'Brien SJ, Blair DG, et al. : Mechanism of met oncogene activation. Cell 45 : 895-904, 1986 DOI ScienceOn |
18 | Patil SR, Merrick S, Lubs HA : Identification of each human chromosome with a modified Giemsa stain. Science 173 : 821-822, 1971 DOI |
19 | Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, et al. : The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61 : 215-225; discussion 226-219, 2002 |
20 | Lee JY, Finkelstein S, Hamilton RL, Rekha R, King JT Jr, Omalu B : Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas. Neurosurgery 55 : 1163-1173, 2004 DOI ScienceOn |
21 | Lee SH, Kim JH, Rhee CH, Kang YS, Lee JH, Choi KS : Loss of heterozygosity on chromosome 10, 13, 17, and p53 gene mutation in human brain gliomas. J Korean Neurosurg Soc 22 : 537-550, 1993 |
22 | Leuraud P, Marie Y, Robin E, Huguet S, He J, Mokhtari K, et al. : Frequent loss of 1p32 region but no mutation of the p18 tumor suppressor gene in meningiomas. J Neurooncol 50 : 207-213, 2000 DOI ScienceOn |
23 | Bhargava M, Joseph A, Knesel J, Halaban R, Li Y, Pang S, et al. : Scatter factor and hepatocyte growth factor : activities, properties, and mechanism. Cell Growth Differ 3 : 11-20, 1992 |
24 | Liu Y : The human hepatocyte growth factor receptor gene : complete structural organization and promoter characterization. Gene 215 : 159-169, 1998 DOI ScienceOn |
25 | Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. : The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114 : 97-109, 2007 DOI ScienceOn |
26 | Mashiyama S, Murakami Y, Yoshimoto T, Sekiya T, Hayashi K : Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 6 : 1313-1318, 1991 |
27 | Bozzetti C, Bortesi B, Merisio C : Loss of heterozygosity (LOH) in ovarian cancer. Int J Gynaecol Obstet 85 : 294-295, 2004 DOI ScienceOn |
28 | Cooper CS, Park M, Blair DG, Tainsky MA, Huebner K, Croce CM, et al. : Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311 : 29-33, 1984 DOI ScienceOn |
29 | Hollstein M, Sidransky D, Vogelstein B, Harris CC : p53 mutations in human cancers. Science 253 : 49-53, 1991 DOI |
30 | Jeffers M, Rong S, Vande Woude GF : Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol 16 : 1115-1125, 1996 |
31 | Karamitopoulou E, Perentes E, Diamantis I : p53 protein expression in central nervous system tumors : an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies. Acta Neuropathol (Berl) 85 : 611-616, 1993 DOI ScienceOn |
32 | Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW : Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51 : 6304-6311, 1991 |
33 | Arrieta O, Garcia E, Guevara P, Garcia-Navarrete R, Ondarza R, Rembao D, et al. : Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma. Cancer 94 : 3210-3218, 2002 DOI ScienceOn |
34 | Akagi K, Kurahashi H, Arita N, Hayakawa T, Monden M, Mori T, et al. : Deletion mapping of the long arm of chromosome 22 in human meningiomas. Int J Cancer 60 : 178-182, 1995 DOI ScienceOn |